Pharmadrug Inc (PHRX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 09-2017 | 09-2016 | 09-2015 | |
| Sales | 611 | 0 | 0 | N/A | 0 |
| Cost of Goods | 357 | N/A | N/A | N/A | 0 |
| Gross Profit | 253 | N/A | N/A | N/A | 0 |
| Operating Expenses | 5,347 | 951 | 114 | 226 | 717 |
| Operating Income | -5,094 | -951 | -114 | -226 | -717 |
| Interest Expense | 477 | 188 | N/A | N/A | N/A |
| Other Income | -1,411 | -2,374 | -1 | -7,327 | 2 |
| Pre-tax Income | -6,982 | -3,512 | -115 | -7,554 | -714 |
| Income Tax | -443 | N/A | N/A | -41 | -318 |
| Net Income Continuous | -6,539 | -3,512 | -115 | -7,513 | -396 |
| Net Income Discontinuous | 0 | -373 | N/A | N/A | N/A |
| Minority Interests | 249 | N/A | N/A | N/A | N/A |
| Net Income | $-6,290 | $-3,886 | $-115 | $-7,513 | $-396 |
| EPS Basic Total Ops | -0.65 | -2.03 | -0.21 | -12.53 | -0.56 |
| EPS Basic Continuous Ops | -0.65 | -1.82 | -0.21 | -12.53 | -0.56 |
| EPS Basic Discontinuous Ops | 0.00 | -0.21 | N/A | 0.00 | 0.00 |
| EPS Diluted Total Ops | -0.65 | -2.03 | -0.21 | -12.53 | -0.56 |
| EPS Diluted Continuous Ops | -0.65 | -1.82 | -0.21 | -12.53 | -0.56 |
| EPS Diluted Discontinuous Ops | 0.00 | -0.21 | N/A | 0.00 | 0.00 |
| EBITDA(a) | $-5,727 | $-3,324 | $-114 | $-226 | $-716 |